2022 Vol.34(3)

column

Display Mode：          |     

NHCPRC Guidelines
National guidelines for diagnosis and treatment of thyroid cancer 2022 in China (English version)
National Health Commission of the People’s Republic of China
2022, 34(3): 131-150. doi: 10.21147/j.issn.1000-9604.2022.03.01
Abstract(3641) FullText HTML (3114) PDF 1014KB(132) [Cited by] (15)
Abstract:
National guidelines for diagnosis and treatment of breast cancer 2022 in China (English version)
National Health Commission of the People’s Republic of China
2022, 34(3): 151-175. doi: 10.21147/j.issn.1000-9604.2022.03.02
Abstract(3953) FullText HTML (3138) PDF 1771KB(150) [Cited by] (21)
Abstract:
National guidelines for diagnosis and treatment of lung cancer 2022 in China (English version)
National Health Commission of the People’s Republic of China
2022, 34(3): 176-206. doi: 10.21147/j.issn.1000-9604.2022.03.03
Abstract(4542) FullText HTML (3295) PDF 1068KB(156) [Cited by] (19)
Abstract:
National guidelines for diagnosis and treatment of gastric cancer 2022 in China (English version)
National Health Commission of the People’s Republic of China
2022, 34(3): 207-237. doi: 10.21147/j.issn.1000-9604.2022.03.04
Abstract(3825) FullText HTML (3535) PDF 3771KB(163) [Cited by] (19)
Abstract:
National guidelines for diagnosis and treatment of pancreatic cancer 2022 in China (English version)
National Health Commission of the People’s Republic of China
2022, 34(3): 238-255. doi: 10.21147/j.issn.1000-9604.2022.03.05
Abstract(3609) FullText HTML (3144) PDF 2052KB(74) [Cited by] (11)
Abstract:
National guidelines for diagnosis and treatment of cervical cancer 2022 in China (English version)
National Health Commission of the People’s Republic of China
2022, 34(3): 256-269. doi: 10.21147/j.issn.1000-9604.2022.03.06
Abstract(3655) FullText HTML (2735) PDF 1128KB(90) [Cited by] (13)
Abstract:
National guidelines for diagnosis and treatment of prostate cancer 2022 in China (English version)
National Health Commission of the People’s Republic of China
2022, 34(3): 270-288. doi: 10.21147/j.issn.1000-9604.2022.03.07
Abstract(3903) FullText HTML (3246) PDF 991KB(149) [Cited by] (21)
Abstract:
Original Article
Efficacy analysis of Cheng’s GIRAFFE reconstruction after proximal gastrectomy for adenocarcinoma of esophagogastric junction
Zhiyuan Xu, Can Hu, Yanqiang Zhang, Ling Huang, Litao Yang, Jianfa Yu, Pengfei Yu, Jiahui Chen, Yian Du, Xiangdong Cheng
2022, 34(3): 289-297. doi: 10.21147/j.issn.1000-9604.2022.03.08
Abstract(1733) FullText HTML (1461) PDF 7869KB(55) [Cited by] (2)
Abstract:
ObjectiveReconstruction of the digestive tract for adenocarcinoma of esophagogastric junction (AEG) is in dispute. This study evaluated Cheng’s gastric tube interposition esophagogastrostomy with reconstruction of His angle and fundus (Cheng’s GIRAFF...
Symptom burden in advanced breast cancer patients and its association between death anxiety and psychological distress
Zhongge Su, Yuhe Zhou, Xinkun Han, Ying Pang, Shuangzhi He, Lili Tang
2022, 34(3): 298-308. doi: 10.21147/j.issn.1000-9604.2022.03.09
Abstract(1900) FullText HTML (1925) PDF 1352KB(58) [Cited by] (6)
Abstract:
ObjectiveRecent research has documented psychological distress in advanced breast cancer (ABC) patients, but few studies have examined how death anxiety is affected by the symptom burden. Therefore, this study aims to explore the association among sy...